4.4 Article

Association of Symptoms of Depression With Cardiovascular Disease and Mortality in Low-, Middle-, and High-Income Countries

Journal

JAMA PSYCHIATRY
Volume 77, Issue 10, Pages 1052-1063

Publisher

AMER MEDICAL ASSOC
DOI: 10.1001/jamapsychiatry.2020.1351

Keywords

-

Categories

Funding

  1. MaryW. Burke endowed chair of the Heart and Stroke Foundation of Ontario
  2. Population Health Research Institute
  3. Hamilton Health Sciences Research Institute (HHSRI)
  4. Canadian Institutes of Health Research's Strategy for Patient Oriented Research, through Ontario SPOR Support Unit
  5. Ontario Ministry of Health and Long-Term Care
  6. AstraZeneca (Canada)
  7. Sanofi-Aventis (France)
  8. Sanofi-Aventis (Canada)
  9. Boehringer Ingelheim (Germany)
  10. Boehringer Ingelheim (Canada)
  11. Servier
  12. GlaxoSmithKline
  13. Argentina: Fundacion ECLA (Estudios Clinicos Latino America)
  14. Bangladesh: Independent University, Bangladesh
  15. Bangladesh: Mitra and Associates
  16. Brazil: Unilever Health Institute
  17. Chile: Universidad de La Frontera [DI13-PE11]
  18. China: National Center for Cardiovascular Diseases
  19. China: ThinkTank Research Center for Health Development
  20. Colombia: Colciencias [6566-04-18062, 6517-777-58228]
  21. India: Indian Council of Medical Research
  22. Malaysia: Ministry of Science, Technology and Innovation of Malaysia [100-IRDC/BIOTEK 16/6/21 [13/2007], 07-05-IFN-BPH 010]
  23. Malaysia: Universiti Teknologi MARA
  24. Malaysia: Universiti Kebangsaan Malaysia [UKM-Hejim-Komuniti-15-2010]
  25. Occupied Palestinian Territory: the United Nations Relief and Works Agency for Palestine Refugees in the Near East
  26. Philippines: Philippine Council for Health Research and Development
  27. Poland: Polish Ministry of Science and Higher Education [290/W-PURE/2008/0]
  28. Poland: Wroclaw Medical University
  29. South Africa: The North-West University
  30. South Africa: SA and Netherlands Programme for Alternative Development
  31. South Africa: National Research Foundation
  32. South Africa: Medical Research Council of South Africa
  33. South Africa: The South Africa Sugar Association
  34. South Africa: Faculty of Community and Health Sciences
  35. Sweden: Swedish Heart and Lung Foundation
  36. Sweden: Swedish Research Council
  37. Sweden: Swedish Council for Health, Working Life andWelfare
  38. Sweden: King Gustaf V and Queen Victoria Freemason's Foundation
  39. Sweden: AFA Insurance
  40. Turkey: Metabolic Syndrome Society
  41. Turkey: AstraZeneca
  42. Turkey: Sanofi Aventis
  43. United Arab Emirates: Sheikh Hamdan Bin Rashid Al Maktoum Award For Medical Sciences
  44. United Arab Emirates: Dubai Health Authority, Dubai
  45. Dairy Farmers of Canada
  46. National Dairy Council (US)
  47. Public Health Agency of Canada
  48. Champlain Cardiovascular Disease Prevention Network
  49. Saudi Arabia: Saudi Heart Association
  50. Saudi Arabia: Saudi Gastroenterology Association
  51. Saudi Arabia: Dr Mohammad Alfagih Hospital
  52. Saudi Arabia: King Saud University
  53. Occupied Palestinian Territory: International Development Research Centre (Canada)
  54. Malaysia: Ministry of Higher Education of Malaysia [600-RMI/LRGS/5/3 [2/2011]]
  55. Canadian Institutes of Health Research
  56. Heart and Stroke Foundation of Ontario
  57. Novartis
  58. King Pharma
  59. [RG -1436-013]

Ask authors/readers for more resources

This cohort study identifies associations between depressive symptoms and incident cardiovascular disease and all-cause mortality in countries at different levels of economic development and in urban and rural areas Importance Depression is associated with incidence of and premature death from cardiovascular disease (CVD) and cancer in high-income countries, but it is not known whether this is true in low- and middle-income countries and in urban areas, where most people with depression now live. Objective To identify any associations between depressive symptoms and incident CVD and all-cause mortality in countries at different levels of economic development and in urban and rural areas. Design, Setting, and Participants This multicenter, population-based cohort study was conducted between January 2005 and June 2019 (median follow-up, 9.3 years) and included 370 urban and 314 rural communities from 21 economically diverse countries on 5 continents. Eligible participants aged 35 to 70 years were enrolled. Analysis began February 2018 and ended September 2019. Exposures Four or more self-reported depressive symptoms from the Short-Form Composite International Diagnostic Interview. Main Outcomes and Measures Incident CVD, all-cause mortality, and a combined measure of either incident CVD or all-cause mortality. Results Of 145862 participants, 61235 (58%) were male and the mean (SD) age was 50.05 (9.7) years. Of those, 15983 (11%) reported 4 or more depressive symptoms at baseline. Depression was associated with incident CVD (hazard ratio [HR], 1.14; 95% CI, 1.05-1.24), all-cause mortality (HR, 1.17; 95% CI, 1.11-1.25), the combined CVD/mortality outcome (HR, 1.18; 95% CI, 1.11-1.24), myocardial infarction (HR, 1.23; 95% CI, 1.10-1.37), and noncardiovascular death (HR, 1.21; 95% CI, 1.13-1.31) in multivariable models. The risk of the combined outcome increased progressively with number of symptoms, being highest in those with 7 symptoms (HR, 1.24; 95% CI, 1.12-1.37) and lowest with 1 symptom (HR, 1.05; 95% CI, 0.92 -1.19; P for trend < .001). The associations between having 4 or more depressive symptoms and the combined outcome were similar in 7 different geographical regions and in countries at all economic levels but were stronger in urban (HR, 1.23; 95% CI, 1.13-1.34) compared with rural (HR, 1.10; 95% CI, 1.02-1.19) communities (P for interaction = .001) and in men (HR, 1.27; 95% CI, 1.13-1.38) compared with women (HR, 1.14; 95% CI, 1.06-1.23; P for interaction < .001). Conclusions and Relevance In this large, population-based cohort study, adults with depressive symptoms were associated with having increased risk of incident CVD and mortality in economically diverse settings, especially in urban areas. Improving understanding and awareness of these physical health risks should be prioritized as part of a comprehensive strategy to reduce the burden of noncommunicable diseases worldwide. Question Does the increased risk of incident cardiovascular disease and mortality in middle-aged adults with depressive symptoms vary across and within countries? Findings In this cohort study from 21 countries and 145862 participants, cardiovascular events and death increased by 20% in people with 4 or more depressive symptoms compared with people without. The relative risk increased in countries at all economic levels but was more than twice as high in urban than rural areas. Meaning Adults with depressive symptoms experience poor physical health outcomes and increased risk of mortality across the world and in different settings, especially in urban areas.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available